Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for treatment of gastroesophageal reflux disease (GERD) in neonatal patients
2006-002001-31Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in gastroesophageal reflux disease (GERD) comparing Esomeprazole arm with Placebo arm (2 arms). Primary endpoint: Primary GERD symptom and sign change. Started Sep 2006; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on 2006-002001-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002001-31.